跳转至内容
Merck
CN

346330

Sigma-Aldrich

反式-3-溴-N-乙基肉桂酰胺

99%

登录查看公司和协议定价

选择尺寸


关于此项目

线性分子式:
BrC6H4CH=CHCONHC2H5
化学文摘社编号:
分子量:
254.12
MDL编号:
UNSPSC代码:
12352100
PubChem化学物质编号:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

方案

99%

mp

89-91 °C (lit.)

SMILES字符串

CCNC(=O)\C=C\c1cccc(Br)c1

InChI

1S/C11H12BrNO/c1-2-13-11(14)7-6-9-4-3-5-10(12)8-9/h3-8H,2H2,1H3,(H,13,14)/b7-6+

InChI key

LDCXGZCEMNMWIL-VOTSOKGWSA-N

正在寻找类似产品? 访问 产品对比指南

象形图

Exclamation mark

警示用语:

Warning

危险声明

预防措施声明

危险分类

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

11 - Combustible Solids

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

E A Lane et al.
Journal of pharmaceutical sciences, 72(5), 493-496 (1983-05-01)
Fifty percent of a cinromide dose was metabolized to an active metabolite in the rhesus monkey. The steady-state concentration of this metabolite was 3-6 times that of the parent drug, depending on the route of administration. Cinromide is a medium-extraction
Prediction of steady-state behavior of metabolite from dosing of parent drug.
E A Lane et al.
Journal of pharmaceutical sciences, 69(5), 610-612 (1980-05-01)
A J Wilensky et al.
Epilepsia, 24(4), 401-409 (1983-08-01)
Monotherapy with the experimental antiepileptic drug cinromide was evaluated in 11 adult outpatients with uncontrolled partial epilepsy. They were treated with phenytoin for 2 months, cinromide for 4 months, and carbamazepine for 4 months. Four patients withdrew from the study
E A Lane et al.
Journal of pharmaceutical sciences, 72(11), 1352-1354 (1983-11-01)
The dose-dependent nonlinearity of the clearance of cinromide, a medium extraction ratio drug, has been established in two monkeys. Special problems encountered in evaluation of nonlinearity of such drugs were resolved by the experimental design: cinromide was infused to steady
E A Lane et al.
Journal of pharmacokinetics and biopharmaceutics, 13(4), 373-386 (1985-08-01)
A previous study of the metabolic fate of cinromide (3-bromo-N-ethylcinnamamide) in rhesus monkey established that half of a dose is metabolized by N-deethylation to an active metabolite, 3-bromocinnamamide. Both cinromide and its proximal metabolite can be metabolized by amide hydrolysis

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持